ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 118 filers reported holding ATEA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.5%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $58,356 | -47.5% | 19,452 | -34.5% | 0.00% | – |
| Q2 2023 | $111,082 | +135.8% | 29,701 | +111.2% | 0.00% | – |
| Q1 2023 | $47,114 | +1859.0% | 14,064 | +2712.8% | 0.00% | – |
| Q4 2022 | $2,405 | -39.9% | 500 | -28.1% | 0.00% | – |
| Q3 2022 | $4,000 | -60.0% | 695 | -47.2% | 0.00% | – |
| Q2 2022 | $10,000 | -95.4% | 1,317 | -95.7% | 0.00% | – |
| Q1 2022 | $219,000 | -52.7% | 30,333 | -41.4% | 0.00% | – |
| Q4 2021 | $463,000 | -95.3% | 51,763 | -81.6% | 0.00% | -100.0% |
| Q3 2021 | $9,877,000 | +164516.7% | 281,719 | +101237.8% | 0.00% | – |
| Q2 2021 | $6,000 | -97.9% | 278 | -93.9% | 0.00% | – |
| Q1 2021 | $282,000 | -10.8% | 4,566 | -39.6% | 0.00% | – |
| Q4 2020 | $316,000 | – | 7,562 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tyrus Capital S.A.M. | 1,260,000 | $4,712,400 | 33.11% |
| BML Capital Management, LLC | 2,236,239 | $8,363,534 | 7.52% |
| TANG CAPITAL MANAGEMENT LLC | 3,026,455 | $11,318,942 | 1.67% |
| Stonepine Capital Management, LLC | 752,088 | $2,812,809 | 1.02% |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $9,296,286 | 0.96% |
| CM Management, LLC | 250,000 | $935 | 0.91% |
| EcoR1 Capital, LLC | 6,995,861 | $26,164,520 | 0.64% |
| Cormorant Asset Management, LP | 1,547,181 | $5,786,457 | 0.32% |
| SECTORAL ASSET MANAGEMENT INC | 501,537 | $1,875,748 | 0.31% |
| Auour Investments LLC | 177,000 | $661,980 | 0.28% |